Search Site

Ian M. Kronish, MD

  • Assistant Professor of Medicine
  • Co-Director, ColumbiaDoctors Hypertension Center
  • Director, ActiveBP: 24-Hour Ambulatory Blood Pressure Monitoring Service
Ian M. Kronish, MD

Dr. Kronish obtained his medical degree from Harvard Medical School and completed his residency and fellowship in internal medicine at Mount Sinai Medical Center. He is a board-certified general internist and Associate Professor of Medicine in the Division of Cardiology and Division of General Medicine at Columbia University Medical Center.

He co-directs the ColumbiaDoctors Hypertension Center, a multidisciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for hypertension. He also directs a 24-hour ambulatory blood pressure monitoring service, called ActiveBP. Dr. Kronish’s clinical interests include the accurate diagnosis and treatment of hypertension, as well as the management of psychological consequences of chronic disease.

Dr. Kronish's research aims to to develop, test, and implement interventions that improve the diagnosis, treatment, and control of hypertension in primary care. His research also aims to reduce the adverse psychological consequences of acute medical events such as strokes and heart attacks, and to better understand the influence of depression and post-traumatic stress disorder on patient's ability to self-manage their chronic disease. 

Departments And Divisions

  • Department of Medicine

Board Certifications

  • Internal Medicine

Areas of Expertise

  • Primary Care Internist
  • Hypertension
  • High Blood Pressure
  • Mental Health

Languages Spoken

  • French
  • Spanish

Education & Training

  • Harvard Medical School
  • Internship: Mount Sinai Medical Center
  • Residency: Mount Sinai Medical Center
  • Fellowship: Mount Sinai Medical Center

Provider Affiliations

  • NewYork-Presbyterian/Columbia

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • Aetna [EPO, HMO, Medicare Managed Care, NY Signature, POS, PPO, Signature Administrators, Student Health]
  • Cigna [EPO, Great West, HMO, POS, PPO]
  • Empire Blue Cross Blue Shield [Blue Priority, EPO, HMO, Medicare (Mediblue), NYP Employee Plan, Pathway (Exchange), POS, PPO]
  • Local 1199 [Local 1199]
  • MagnaCare [MagnaCare]
  • Multiplan [Multiplan]
  • Oxford Health Plans [Freedom, Liberty, Medicare Managed Care]
  • POMCO [POMCO]
  • UnitedHealthcare [Columbia University Employee Plan, Compass (Exchange), EPO, Essential Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]

This provider does not accept new patients

Contact Phone Number: (212) 305-6354

Lab Locations

  • Presbyterian Hospital Building (PH)

    622 West 168th Street
    PH 9, Room 311
    New York, NY 10032
    Lab Phone:
    (212) 342-1335
    Email:
    ik2293@cumc.columbia.edu

Committees/Societies/Memberships

Fellow, American Heart Association

Member, Society of General Internal Medicine

Member, American Psychosomatic Society

NIH Grants

  • RE-ENGINEERING PRECISION THERAPEUTICS THROUGH N-OF-1 TRIALS (Federal Gov)

    Sep 1 2017 - May 31 2022

    COLUMBIA UNIVERSITY SCIENCE OF BEHAVIOR CHANGE RESOURCE AND COORDINATING CENTER (Federal Gov)

    Sep 30 2015 - May 31 2020

    IMPACT OF PTSD ON CARDIOVASCULAR RISK IN SURVIVORS OF STROKE AND TRANSIENT ISCHEMIC ATTACK (Federal Gov)

    Jun 20 2016 - Mar 31 2020

    TEST OF A NEW THEORY TO EXPLAIN EXCESS RISK IN CARDIAC PTSD (Federal Gov)

    Jul 15 2015 - Mar 31 2019

    BUILDING MULTISTAGE TREATMENT POLICY FOR DEPRESSION AFTER ACUTE CORONARY SYNDROME (Federal Gov)

    Aug 17 2016 - Jul 31 2018

    DEPRESSING SCREENING RCT IN ACS PATIENTS: QUALITY OF LIFE AND COST OUTCOMES (Federal Gov)

    Aug 1 2013 - Jul 31 2018

    ENGAGING STAKEHOLDERS IN BUILDING PATIENT-CENTERED N-OF-1 RANDOMIZED AND OTHER CONTROLLED TRIAL METHODS (Private)

    Dec 1 2014 - Jun 30 2018

    DESIGNING A PROTOTYPE OF N-OF1 TRIALS OF DEPRESSIVE SYMPTOM MANAGEMENT IN CANCER SURVIVORS (Federal Gov)

    Sep 26 2015 - Feb 28 2018

    CARDIOVASCULAR INFLAMMATION REDUCTION TRIAL (CIRT) (Federal Gov)

    Feb 1 2013 - Jan 31 2018

    ENGAGING STAKEHOLDERS IN BUILDING PATIENT-CENTERED N-OF-1 RANDOMIZED AND OTHER CONTROLLED TRIAL METHODS (Private)

    Dec 1 2014 - Nov 30 2017

    DESIGNING A PROTOTYPE OF N-OF1 TRIALS OF DEPRESSIVE SYMPTOM MANAGEMENT IN CANCER SURVIVORS (Federal Gov)

    Sep 26 2015 - Sep 29 2017

    PHASE III BREAST CANCER CLINICAL RIALS AND MULTIPLE CHRONIC CONDITION: A SURVEY OF WWW.CLINICALTRIALS.GOV (Federal Gov)

    May 1 2017 - Sep 10 2017

    CLINICAL TRIALS AND MCC (Federal Gov)

    Mar 31 2016 - Jan 31 2017

    UNCONTROLLED HYPERTENSION: THE ROLE OF MEDICATION ADHERENCE AND CLINICAL INERTIA (Federal Gov)

    Sep 1 2010 - May 31 2016

    DESIGNING A PROTOTYPE OF N-OF1 TRIALS OF DEPRESSIVE SYMPTOM MANAGEMENT IN CANCER SURVIVORS (Federal Gov)

    Sep 26 2015 - Jan 25 2016

    TELEMONITORING MEDICATION ADHERENCE TO PREVENT HEART FAILURE READMISSIONS: A PILOT STUDY (NY State Gov)

    Jul 1 2014 - Jun 30 2015